Remarkable effectiveness of tocilizumab in familial Mediterranean fever exon 3 variant with severe abdominal pain and PFAPA-like symptoms: a child case report and review of the literature

References

• Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–1885.
   PubMed Web of Science ®Google Scholar
• Ryan JG, Masters SL, Booty MG, et al. Clinical features and functional significance of the P369S/R408Q variant in pyrin, the familial Mediterranean fever protein. Ann Rheum Dis. 2010;69:1383–1388.
   PubMed Web of Science ®Google Scholar
• Migita K, Agematsu K, Yazaki M, et al. Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore). 2014;93:158–164.
   PubMed Web of Science ®Google Scholar
• Kubota K, Ohnishi H, Teramoto T, et al. Clinical and genetic characterization of Japanese sporadic cases of periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome from a single medical center in Japan. J Clin Immunol. 2014;34:584–593.
   PubMed Web of Science ®Google Scholar
• Migita K, Ida H, Moriuchi H, et al. Clinical relevance of MEFV gene mutations in Japanese patients with unexplained fever. J Rheumatol. 2012;39:875–877.
   PubMed Web of Science ®Google Scholar
• Marshall GS, Edwards KM, Lawton AR. PFAPA syndrome. Pediatr Infect Dis J. 1989;8:658.
   PubMed Web of Science ®Google Scholar
• Thomas KT, Feder HM, Jr., Lawton AR, et al. Periodic fever syndrome in children. J Pediatr. 1999;135:15–21.
   PubMed Web of Science ®Google Scholar
• Shinar Y, Tohami T, Livneh A, et al. Acquired familial Mediterranean fever associated with a somatic MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis. Orphanet J Rare Dis. 2015;10. DOI:10.1186/s13023-015-0298-6
   Web of Science ®Google Scholar
• Perko D, Debeljak M, Toplak N, et al. Clinical features and genetic background of the periodic fever syndrome with aphthous stomatitis, pharyngitis, and adenitis: a single center longitudinal study of 81 patients. Mediat Inflamm. 2015;2015:1.
   Google Scholar
• Yabuuchi J, Hayami N, Hoshino J, et al. AA amyloidosis and atypical familial Mediterranean fever with exon 2 and 3 mutations. Case Rep Nephrol Dial. 2017;7:102–107.
   Web of Science ®Google Scholar
• Shimizu M, Tone Y, Toga A, et al. Colchicine-responsive chronic recurrent multifocal osteomyelitis with MEFV mutations: a variant of familial Mediterranean fever? Rheumatology (Oxford). 2010;49:2221–2223.
   PubMed Web of Science ®Google Scholar
• Kubota K, Ohnishi H, Teramoto T, et al. In vitro analysis of the functional effects of an NLRP3 G809S variant with the co-existence of MEFV haplotype variants in atypical autoinflammatory syndrome. J Clin Immunol. 2013;33:325–334.
   Web of Science ®Google Scholar
• Yamagami K, Nakamura T, Nakamura R, et al. Familial Mediterranean fever with P369S/R408Q exon3 variant in pyrin presenting as symptoms of PFAPA. Mod Rheumatol. 2017;27:356–359.
   PubMed Web of Science ®Google Scholar
• Hannan LM, Ward J, Ebringer R, et al. Late presentation of familial Mediterranean fever associated with P369S/R408Q variant in the MEFV gene. Intern Med J. 2012;42:952–954.
   Web of Science ®Google Scholar
• Fujikawa K, Migita K, Nagasato A, et al. Mediterranean fever (MEFV) variant P369S/R408Q in a patient with Entero-Behcet's disease who successfully responded to treatment with colchicine. Intern Med. 2014;53:2381–2384.
   Web of Science ®Google Scholar
• Fujikawa K, Migita K, Shigemitsu Y, et al. MEFV gene polymorphisms and TNFRSF1A mutation in patients with inflammatory myopathy with abundant macrophages. Clin Exp Immunol. 2014;178:224–228.
   Web of Science ®Google Scholar
• Fujikawa K, Migita K, Tsukada T, et al. Protracted febrile myalgia syndrome in a Japanese patient with fasciitis detected on MRI. Intern Med. 2014;53:2817–2819.
   Web of Science ®Google Scholar
• Migita K, Abiru S, Sasaki O, et al. Coexistence of familial Mediterranean fever and rheumatoid arthritis. Mod Rheumatol. 2014;24:212–216.
   PubMed Web of Science ®Google Scholar
• Inamo Y, Hayashi R, Saito K, et al. A Japanese pediatric patient with coexisting systemic lupus erythematosus and familial Mediterranean fever. Lupus. 2013;22:1056–1059.
   Web of Science ®Google Scholar
• Matsuda M, Kishida D, Tsuchiya-Suzuki A, et al. Periodic peritonitis due to familial Mediterranean fever in a patient with systemic lupus erythematosus. Intern Med. 2010;49:2259–2262.
   PubMed Web of Science ®Google Scholar
• Cekin N, Akyurek ME, Pinarbasi E, et al. MEFV mutations and their relation to major clinical symptoms of Familial Mediterranean Fever. Gene. 2017;626:9–13.
   PubMed Web of Science ®Google Scholar
• Koga T, Migita K, Kawakami A. Biologic therapy in familial Mediterranean fever. Mod Rheumatol. 2016;26:637–641.
   PubMed Web of Science ®Google Scholar
• Hagihara K, Nishikawa T, Isobe T, et al. IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun. 2004;314:363–369.
   PubMed Web of Science ®Google Scholar
• Fujikawa K, Migita K, Tsukada T, et al. Interleukin-6 targeting therapy in familial Mediterranean fever. Clin Exp Rheumatol. 2013;31:150–151.
   PubMed Web of Science ®Google Scholar
• Umeda M, Aramaki T, Fujikawa K, et al. Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis. Int J Rheum Dis. 2017;20:1868–1871.
   PubMed Web of Science ®Google Scholar
• Hamanoue S, Suwabe T, Hoshino J, et al. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever. Mod Rheumatol. 2016;26:610–613.
   PubMed Web of Science ®Google Scholar
• Yilmaz S, Cinar M, Simsek I, et al. Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever. Rheumatology (Oxford). 2015;54:564–565.
   PubMed Web of Science ®Google Scholar
• Celiksoy MH, Ogur G, Yaman E, et al. Could familial Mediterranean fever gene mutations be related to PFAPA syndrome? Pediatr Allergy Immunol. 2016;27:78–82.
   PubMed Web of Science ®Google Scholar
• Sugiura T, Kawaguchi Y, Fujikawa S, et al. Familial Mediterranean fever in three Japanese patients, and a comparison of the frequency of MEFV gene mutations in Japanese and Mediterranean populations. Mod Rheumatol. 2008;18:57–59.
   PubMed Web of Science ®Google Scholar